Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open label, multicentre study, evaluating the safety, tolerability, efficacy, compliance and the acceptability of alkalising treatments at long-term in patients with cystinuria

Next Previous
Trial Profile

Open label, multicentre study, evaluating the safety, tolerability, efficacy, compliance and the acceptability of alkalising treatments at long-term in patients with cystinuria

Status: Withdrawn prior to enrolment
Phase of Trial: Phase II/III

Latest Information Update: 15 Mar 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Potassium bicarbonate/potassium citrate (Primary) ; Potassium bicarbonate; Potassium citrate; Sodium bicarbonate; Sodium citrate
  • Indications Cystinuria
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors Advicenne

    • Most Recent Events

    • 08 Mar 2024 Planned End Date changed from 1 Aug 2022 to 1 Aug 2025.
    • 08 Mar 2024 Planned primary completion date changed from 1 Aug 2022 to 1 Jun 2025.
    • 08 Mar 2024 Planned initiation date changed to 1 May 2024.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top